Engineering a long-acting relaxin agonist to treat liver fibrosis Grant

Engineering a long-acting relaxin agonist to treat liver fibrosis .

date/time interval

  • September 1, 2021 - August 31, 2022

awarded by

subcontracted through

administered by

sponsor award ID

  • Agreement

contributor